GlassScriptPhysician profile
Brittany Jackson
NPI 1649964123
$1,261.20
in general payments reported to CMS, 2019-2025
21 companies · $270 in 2025
The $270 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $284 · 2024: $707 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,261.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $250.80 | 2023-2025 | Xtampza |
| Forte Bio-Pharma LLC | $220.47 | 2023-2025 | Prolate, Nalocet, Tanlor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $193.45 | 2023-2024 | Relistor |
| Medtronic, INC. | $106.07 | 2023-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Valinor Pharma, LLC | $60.57 | 2023 | Movantik |
| Si-Bone, INC. | $57.07 | 2024-2025 | |
| Scilex Pharmaceuticals INC. | $48.05 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $40.89 | 2025 | |
| Spinal Simplicity, LLC | $34.48 | 2024-2025 | Ha Minuteman G3-R |
| Avanos Medical | $28.86 | 2024 | Coolief* Cooled Radiofrequency |
| Azurity Pharmaceuticals, INC. | $27.28 | 2023-2024 | Horizant, Horizant |
| Fidia Pharma USA INC. | $23.85 | 2023 | Triluron, Hymovis |
| Pfizer INC. | $23.63 | 2024 | |
| Biotronik Nro, INC. | $22.17 | 2025 | Prospera |
| Astellas Pharma US INC | $22.12 | 2025 | Xtandi |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $21.84 | 2025 | Clottriever Bold Catheter |
| Curonix LLC | $20.32 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pacira Pharmaceuticals Incorporated | $16.48 | 2023 | Zilretta, Iovera |
| Becton, Dickinson and Company | $14.75 | 2024 | Venclose Maven Catheter |
| Averitas Pharma INC. | $14.25 | 2024 | Qutenza |
| Bioventus LLC | $13.80 | 2023 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.